Alternative mix-and-match COVID-19 vaccine administration versus standard vaccination for prevention of severe COVID-19:A specific cost utility analysis

• 作者: Rujittika Mungmunpuntipantip Viroj Wiwanitkit
• 来源期刊: 亚太热带医药杂志（英文版）
• 年，卷（期）: 2022,（2）
• 所属期刊栏目: Letters to Editor
• 页码范围: 93-94
• 页数: 2页
• 语种: 英文
• DOI: 10.4103/1995-7645.338431

摘要

Till now,over 220 million people throughout the world have already been affected by coronavirus disease(COVID-19).Vaccination is the most effective strategy to prevent the spread of COVID-19[1].Several pharmaceutical companies have announced the success of their COVID-19 vaccine study.Additional publications on the vaccine1s efficacy and inoculation costs are available.When it comes to a new immunization,the cost and accessibility of the vaccine are crucial considerations[2].In most cases,it is necessary to administer two intramuscular vaccine doses.While some scientists provide strategies for reducing the risk and overcoming the problem of insufficient COVID-19 vaccination supply by administering COVID-19 in a different way.Hence,a concern on utility of the new COVID-19 vaccine should be able to prevent overall COVID-19 and severe infection.The efficacy of COVID-19 vaccinations has been decreased due to the introduction of new variations of concern.